Implies the FDA can use their reasoning ability to do the right thing, rather than allow a computer to calculate whether or not to allow a drug to save lives and reduce suffering.
Refreshing, optimistic.
However, the FDA credibility has been tarnished by their approvals of remdeathsivir and plasma, so they IMO, have stuck their foot in the door of the DSMB and are being "tedious" to be sure that their upcoming decision for EUA for Leronlimab will be a solid move (as we know it will).